Bapid | Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

Clinically significant adverse reactions: Leukopenia (incidence <0.1%) and thrombocytopenia (incidence unknown) may occur. Patients should be closely monitored. If abnormal laboratory findings are observed, the drug should be discontinued and appropriate measures taken.
Hepatic dysfunction (incidence <0.1%) and jaundice (incidence unknown), as indicated by increases in AST (GOT), ALT (GPT), γ-GTP, and alkaline phosphatase levels have been reported in patients receiving Rebamipide. If abnormal laboratory findings are observed, the drug should be discontinued and appropriate measures taken.
Other adverse reactions: See table.

Click on icon to see table/diagram/image

View ADR Reporting Link

Bapid Adverse Reactions

rebamipide

Manufacturer:

Unison

Distributor:

Medline

Marketer:

B.Grimm Pharma